The epidemiological analysis of contact allergy;Die epidemiologische analyse der kontaktallergien

Allergologie

Volumn 32, Issue 7, 2009, Pages 250-255

  Uter, W ^a   Schnuch, A ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Clinical epidemiology; Contact allergy; Public health

Indexed keywords

ALLERGEN; BUFEXAMAC; FRAGRANCE; NEOMYCIN; NICKEL; PHENYLENEDIAMINE;

CLINICAL STUDY; CONCENTRATION (PARAMETERS); CONTACT ALLERGY; DERMATOLOGY; DIAGNOSTIC TEST; GENDER; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; PATCH TEST; PHENOTYPE; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 68449089926     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp32250     Document Type: Review

References (25)

1. Brasch J, Geier J, Schnuch A. Differenzierte Kontaktallergenlisten dienen der Qualitätsverbesserung: Ergebnisse aus der Kooperation von DKG und IVDK (Daten aus 24 Hautkliniken). Hautarzt. 1998; 49: 184-191.
2. Hermann-Kunz E. Allergische Krankheiten in Deutschland. Ergebnisse einer repräsentativen Studie. Bundesgesundheitsbl-Gesundheitsforsch- Gesundheitsschutz. 2000; 43: 400-406.
3. Menezes de Padua CA, Schnuch A, Lessmann H et al. Contact allergy to neomycin sulfate - results of a multifactorial analysis. Pharmacoepidemiology and Drug Safety. 2005; 14: 725-733. (Pubitemid 41489453)
4. Menezes de Padua CA, Schnuch A, Nink K et al. Allergic contact dermatitis to topical drugs - epidemiological risk assessment. Pharmacoepidemiol Drug Saf. 2008; 17: 813-821.
5. Menezes de Padua CA, Uter W, Schnuch A. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level. Pharmacoepidemiol Drug Saf. 2007; 16: 377-384. (Pubitemid 46661425)
6. Schäfer T, Böhler E, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy. 2001; 56: 1192-1196.
7. Schnuch A. PAFS: population-adjusted frequency of sensitization. I. Influence of sex and age. Contact Dermatitis. 1996; 34: 377-382.
8. Schnuch A, Brasch J, Uter W. Polysensitization and increased susceptibility in contact allergy: a review. Allergy. 2008; 63: 156-167.
9. Schnuch A, Geier J, Lessmann H et al. Rückgang der Nickelkontaktallergie in den letzten Jahren. Eine Folge der "Nickel- Verordnung"? Auswertungen der Daten des IVDK der Jahre 1992 - 2001 (Decrease in nickel sensitization in young patients - successful intervention through nickel exposure regulation? Results of IVDK, 1992 - 2001). Hautarzt. 2003; 54: 626-632.
10. Schnuch A, Geier J, Uter W. Der Informationsverbund Dermatologischer Kliniken (IVDK). Klinische Epidemiologie zur Prävention des Allergischen Kontaktekzems (Information Society of Dermatological Clinics. Clinical epidemiology for prevention of allergic contact eczema). Hautarzt. 2001; 52: 582-585.
11. Schnuch A, Geier J, Uter W et al. National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis. 1997; 37: 200-209.
12. Schnuch A, Lessmann H, Frosch PJ et al. Para- Phenylenediamine: the profile of an important allergen. Results of the IVDK. Br J Dermatol. 2008; 159: 379-386. (Pubitemid 352009841)
13. Schnuch A, Lessmann H, Geier J et al. Contact allergy to fragrances: frequencies of sensitization from 1996 to 2002. Results of the IVDK. Contact Dermatitis. 2004; 50: 65-76.
14. Schnuch A, Uter W, Gefeller O. Eine heimtückische und häufige Nebenwirkung: Das Ekzemtherapeutikum Bufexamac verursacht Kontaktallergien. Ergebnisse des IVDK. Deutsche Medizinische Wochenschrift. 2005; 130: 2881-2886.
15. Schnuch A, Uter W, Geier J et al. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach. Contact Dermatitis. 2002; 47: 32-39.
16. Schnuch A, Uter W, Lessmann H et al. Klinische Epidemiologie der Kontaktallergien. Das Register und das Überwachungssystem des Informationsverbundes Dermatologischer Kliniken (IVDK). Allergo J. 2008; 17: 611-624.
17. Thyssen JP, Uter W, Schnuch A et al. 10-year prevalence of contact allergy in the general population in Denmark estimated through the CE-DUR method. Contact Dermatitis. 2007; 57: 265-272. (Pubitemid 47397800)
18. Uter W, Gefeller O, Geier J et al. Changes of the patch test population (MOAHLFA index) in long-term participants of the Information Network of Departments of Dermatology, 1999 - 2006. Contact Dermatitis. 2008; 59: 56-57.
19. Uter W, Geier J, Lessmann H et al. Is contact allergy to glyceryl monothioglycolate still a problem in Germany? Contact Dermatitis. 2006; 55: 54-56.
20. Uter W, Lessmann H, Geier J et al. Contact allergy to hairdressing allergens in female hairdressers and clients - current data from the IVDK, 2003 - 2006. J Dtsch Dermatol Ges. 2007; 5: 993-1001.
21. Uter W, Ludwig A, Balda BR et al. The prevalence of contact allergy differed between population- based and clinic-based data. J Clin Epidemiol. 2004; 57: 627-632. (Pubitemid 38891501)
22. Uter W, Rühl R, Pfahlberg A et al. Contact allergy in construction workers: results of a multifactorial analysis. Ann Occup Hyg. 2004; 48: 21-27. (Pubitemid 38112049)
23. Uter W, Schnuch A, Gefeller O. Guidelines for the descriptive presentation and statistical analysis of contact allergy data. Contact Dermatitis. 2004; 51: 47-56. (Pubitemid 39331595)
24. Uter W, Schnuch A, Geier J et al. Assoziation zwischen Beruf und Kontaktsensibilisierung gegen den Duftstoff-Mix - eine multifaktorielle Analyse von Daten des Informationsverbundes Dermatologischer Kliniken (IVDK). Akt Dermatol. 2003; 29: 169-175. (Pubitemid 36717695)
25. Wilkinson JD, Hambly EM, Wilkinson DS. Comparison of patch test results in two adjacent areas of England. II. Medicaments. Acta Derm Venereol. 1980; 60: 245-249.